Chemed Corp
Ownership
Ownership Structure
Who owns Chemed Corp (CHE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.6% of the shares are freely tradable; institutional investors hold 104.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 10.23 | 1,336,690 | +4.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 6.24 | 815,699 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.87 | 636,070 | +0.0 | 03/31/2026 |
| JPMorgan Chase & Co | 3.83 | 500,987 | -4.0 | 03/31/2026 |
| State Street Corp | 3.54 | 462,170 | +0.9 | 03/31/2026 |
| AQR Capital Management LLC | 3.18 | 415,612 | +27.7 | 03/31/2026 |
| Geode Capital Management, LLC | 3.15 | 411,046 | +14.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.56 | 464,871 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.27 | 427,350 | +0.3 | 07/31/2026 |
| Vanguard Small Cap Index | 2.36 | 308,433 | +0.3 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Mcnamara Kevin J | president and CEO | 70,418 | 35,596,299 $ | Aug 21, 2026 | direct |
| Lee Spencer S | executive vice president | 13,912 | 7,032,516 $ | Aug 21, 2026 | direct |
| Grace Patrick P | Director | 3,533 | 1,785,932 $ | Jul 31, 2026 | direct |
| Judkins Brian C | VP and Chief Legal Officer | 3,344 | 1,690,392 $ | Aug 10, 2026 | direct |
| Wherley Joel L | CEO - Vitas Healthcare | 1,181 | 596,996 $ | Aug 5, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Lee Spencer S | executive vice president | Sell | 1,000 | 541.04 | 541,040 |
| Aug 21, 2026 | Mcnamara Kevin J | president and CEO | Sell | 2,000 | 541.16 | 1,082,320 |
| Aug 10, 2026 | Judkins Brian C | VP and Chief Legal Officer | Other | 5,878 | 548.96 | 3,226,787 |
| Aug 10, 2026 | Judkins Brian C | VP and Chief Legal Officer | Other | 6,786 | 445.35 | 3,022,145 |
| Aug 5, 2026 | Wherley Joel L | CEO - Vitas Healthcare | Other | 2,270 | 542.62 | 1,231,747 |
| Aug 5, 2026 | Wherley Joel L | CEO - Vitas Healthcare | Other | 2,599 | 445.35 | 1,157,465 |
| Aug 3, 2026 | Mcnamara Kevin J | president and CEO | Sell | 2,000 | 539.51 | 1,079,020 |
| Jul 31, 2026 | Mcnamara Kevin J | president and CEO | Other | 19,802 | 529.22 | 10,479,614 |
| Jul 31, 2026 | Mcnamara Kevin J | president and CEO | Other | 2,001 | 445.35 | 891,145 |
| Jul 31, 2026 | Grace Patrick P | Director | Sell | 190 | 532.00 | 101,080 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.